Primidone for Chronic Alcohol-Related Tremor: Starting Dose and Side Effects
Start primidone at 50-62.5 mg at bedtime for chronic alcohol-related tremor, with the most common acute side effects being severe nausea, vomiting, dizziness, sedation, and ataxia occurring after the first few doses.
Starting Dose and Titration
The FDA-approved dosing regimen for primidone begins at 100-125 mg at bedtime for adults and children over 8 years 1. However, given the high risk of acute intolerance (occurring in 32-82% of patients) 2, 3, I strongly recommend starting at 50-62.5 mg at bedtime to minimize acute neurotoxic reactions 3.
Recommended Titration Schedule:
- Days 1-3: 50-62.5 mg at bedtime
- Days 4-6: 50-62.5 mg twice daily
- Days 7-9: 100 mg twice daily
- Day 10 onward: Increase to 125 mg three times daily (375 mg/day total)
- Maintenance: 250 mg three times daily (750 mg/day) if needed
Critical caveat: Low doses (250 mg/day) are equally or more effective than high doses (750 mg/day) with significantly fewer side effects 4. Most patients achieve adequate tremor control at 250-375 mg/day divided into 2-3 doses.
Most Common Side Effects
Acute Intolerance (First 1-7 Days)
The most problematic side effects occur with initial dosing 5, 2, 3:
- Severe nausea and vomiting (most common)
- Dizziness and vertigo
- Sedation and drowsiness
- Ataxia and unsteadiness
- Confusion
These acute reactions occur in 82% of patients when starting without phenobarbital pre-treatment 3. The severity peaks within hours of the first dose and is related to primidone itself, not its metabolites 5.
Chronic Side Effects (Weeks to Months)
- Drowsiness and sedation (most common, tends to improve after 3 months)
- Fatigue
- Ataxia
- Cognitive effects
Importantly, chronic side effects with primidone are significantly less problematic than acute reactions—in one study, 0% had significant chronic side effects with primidone versus 17% with propranolol 2.
Strategies to Minimize Acute Intolerance
Consider phenobarbital pre-treatment: Starting phenobarbital 10 mg/day for 2-3 weeks before initiating primidone reduces acute intolerance from 82% to 17% through functional cross-tolerance 3. This approach should be offered to all patients, especially those with prior intolerance to primidone.
Efficacy Considerations
Primidone reduces tremor amplitude by approximately 50-60% 5, 7. The therapeutic effect:
- Begins within 1-7 hours of the first dose 7
- Is maintained for at least 12 months 4, 6
- Does not correlate with serum levels 7
- Is superior to propranolol in head-to-head comparisons 5
Important limitation: Some loss of efficacy may occur with long-term use (tolerance develops in approximately 13% of patients) 2, though tremor suppression remains significantly better than baseline 6.
Monitoring
Therapeutic serum levels are 5-12 mcg/mL 1, though clinical response does not correlate well with levels 7. Monitor for:
- Acute intolerance in first week
- Sedation and ataxia ongoing
- Functional improvement in tremor-related activities